封面
市場調查報告書
商品編碼
1739522

全球生物分解性藥品包裝市場:按材料、產品類型、最終用戶、應用、區域範圍和預測

Global Biodegradable Pharmaceutical Packaging Market by Material, By Product Type, By End User, By Application, By Geographic Scope and Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

生物分解性藥品包裝的市場規模及預測

2024 年生物分解性藥品包裝市場規模為 705 億美元,預計到 2032 年將達到 2,211.7 億美元,在 2026-2032 年預測期內的複合年成長率為 16.2%。

生物分解性藥品包裝涵蓋用於藥品的材料和解決方案,這些材料和解決方案能夠自然、安全、有效地為消費者提供藥品,同時最大限度地減少對環境的危害。此類包裝涵蓋多種材料,包括植物來源塑膠、再生紙和生物分解性聚合物,旨在減少對環境的影響,同時確保藥品的有效性和安全性。生物分解性藥品包裝的未來將專注於開發先進的生物材料、創新的智慧包裝技術和循環經濟模式,以進一步促進永續性,並促進製藥業的環境責任。

生物分解性藥品包裝的全球市場動態

影響全球生物分解性藥品包裝市場的關鍵市場動態是:

關鍵市場促進因素

日益嚴重的環境問題:日益嚴重的環境問題:人們對塑膠污染和環境永續性的認知不斷提高,促使製藥公司採用生物分解性的包裝解決方案,從而顯著促進市場成長並應對全球生態學挑戰。

我們正在處理這些問題。

嚴格的法規:政府法規提倡永續實踐並限制使用一次性塑膠,迫使製藥業轉向生物分解性的包裝替代品,增強合規性和環境責任。

消費者偏好:消費者對環保產品的需求日益成長,促使製藥公司採用生物分解性包裝,以提升其品牌形象,並在重視永續性的市場中提升競爭力。生物分解性材料和製造流程的創新正在提高生物分解性藥品包裝的性能和成本效益,加速整個產業的應用,並促進永續實踐。

主要問題

成本限制:生物分解性材料的生產成本比傳統塑膠更高,這可能會阻礙其廣泛應用。

性能問題:生物分解性包裝面臨的一個主要挑戰是確保與傳統包裝相同等級的藥物保護、穩定性和保存性,同時保持功效和安全標準。

主要趨勢

生物基塑膠:以玉米澱粉和甘蔗等可再生資源為原料的生物基塑膠的開發和應用,在醫藥包裝領域正日益受到關注。智慧生物分解性包裝:隨著智慧技術與生物分解性材料的融合,能夠監測藥物狀態並即時提供資訊的包裝已成為重要趨勢。

邁向循環經濟:製藥公司擴大採用循環經濟原則,重點關注可回收和可堆肥的包裝解決方案,以最大限度地減少廢棄物和對環境的影響。

目錄

第1章 引言

  • 市場定義
  • 市場區隔
  • 調查方法

第2章執行摘要

  • 主要發現
  • 市場概覽
  • 市場亮點

第3章市場概述

  • 市場規模和成長潛力
  • 市場趨勢
  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析

生物分解性藥品包裝市場(依材料)

  • 塑膠
  • 紙和紙板
  • 玻璃
  • 其他

第5章生物分解性藥品包裝市場(依產品類型)

  • 瓶子
  • 泡殼包裝
  • 管瓶/安瓿瓶
  • 小袋和小袋
  • 其他

第6章生物分解性藥品包裝市場(依最終用戶)

  • 製藥商
  • 合約包裝公司
  • 零售藥局
  • 其他

生物分解性藥品包裝市場(依應用)

  • 口服藥物
  • 注射
  • 外用藥物
  • 其他

第8章區域分析

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章市場動態

  • 市場促進因素
  • 市場限制
  • 市場機會
  • COVID-19 市場影響

第10章 競爭格局

  • 主要企業
  • 市場佔有率分析

第11章 公司簡介

  • Gerresheimer AG
  • Berry Global Inc.
  • Amcor plc
  • Becton
  • Dickinson and Company
  • West Pharmaceutical Services Inc.
  • Eastman Chemical Company
  • Schott AG
  • AptarGroup Inc.
  • Nipro Corporation and CCL Industries Inc.

第12章 市場展望市場展望與機會

  • 新興技術
  • 未來市場趨勢
  • 投資機會

第13章 附錄

  • 簡稱列表
  • 來源和參考文獻
簡介目錄
Product Code: 52209

Biodegradable Pharmaceutical Packaging Market Size and Forecast

Biodegradable Pharmaceutical Packaging Market size was valued at USD 70.5 Billion in 2024 and is projected to reach USD 221.17 Billion by 2032 growing at a CAGR of 16.2% from 2026 to 2032.

Biodegradable pharmaceutical packaging includes materials and solutions for drug products that naturally decompose, minimizing environmental harm while ensuring safe and effective containment of pharmaceuticals for consumers.This packaging category encompasses various materials, such as plant-based plastics, recycled paper and biodegradable polymers, all designed to reduce environmental impact while ensuring the efficacy and safety of pharmaceutical products.The future of biodegradable pharmaceutical packaging focuses on developing advanced biomaterials, innovative smart packaging technologies and circular economy models to further enhance sustainability within the pharmaceutical industry and promote environmental responsibility.

Global Biodegradable Pharmaceutical Packaging Market Dynamics

The key market dynamics that are shaping the global biodegradable pharmaceutical packaging market include:

Key Market Drivers:

Growing Environmental Concerns: Increasing awareness of plastic pollution and environmental sustainability is motivating pharmaceutical companies to adopt biodegradable packaging solutions, thereby significantly boosting market growth and addressing global ecological

challenges.

Stringent Regulations: Government regulations promoting sustainable practices and restricting the use of single-use plastics are compelling the pharmaceutical industry to transition toward biodegradable packaging alternatives, enhancing compliance and environmental responsibility.

Consumer Preference: The rising consumer demand for eco-friendly products is prompting pharmaceutical companies to adopt biodegradable packaging options, improving their brand image and increasing competitiveness in a sustainability-conscious market.Technological Advancements: Innovations in biodegradable materials and manufacturing processes are enhancing the performance and cost-effectiveness of biodegradable pharmaceutical packaging, thereby accelerating its adoption across the industry and fostering sustainable practices.

Key Challenges:

Cost Constraints: The higher production costs associated with biodegradable materials compared to traditional plastics can hinder widespread adoption, especially in price-sensitive markets where affordability is a key consideration for companies.

Performance Concerns: A significant challenge for biodegradable packaging is ensuring it provides the same level of protection, stability and shelf life for pharmaceutical products as conventional packaging, maintaining efficacy and safety standards.

Key Trends:

Bio-based Plastics: The development and adoption of bio-based plastics derived from renewable resources like corn starch or sugarcane are gaining traction in pharmaceutical packaging applications.Smart Biodegradable Packaging: Integration of smart technologies with biodegradable materials to create packaging that can monitor drug conditions and provide real-time information is emerging as a key trend.

Circular Economy Initiatives: Pharmaceutical companies are increasingly adopting circular economy principles, focusing on recyclable and compostable packaging solutions to minimize waste and environmental impact.

Global Biodegradable Pharmaceutical Packaging Market Regional Analysis

Here is a more detailed regional analysis of the global biodegradable pharmaceutical packaging market:

Europe:

According to Verified Market Research, Europe is expected to dominate the Global biodegradable pharmaceutical packaging market. The region benefits from stringent environmental regulations, high environmental awareness and strong government support for sustainable practices, driving its market dominance in the sector.

Presence of major pharmaceutical companies and packaging manufacturers with a focus on sustainability contributes to the region's leading position.The growing emphasis on circular economy principles and extended producer responsibility in Europe supports the adoption of biodegradable packaging solutions.Increasing investments in R&D for bio-based materials and collaborations between material science companies and pharmaceutical firms fuel innovation in the region.

Asia-Pacific:

According to Verified Market Research, Asia-Pacific is the fastest growing region in Global biodegradable pharmaceutical packaging market. The region is experiencing rapid growth in its pharmaceutical industry, coupled with increasing environmental concerns, creating significant demand for sustainable packaging solutions.Rising disposable incomes, growing healthcare expenditure and increasing awareness about environmental issues in countries like China and India drive market growth.Government initiatives to reduce plastic waste and promote sustainable practices in several Asian countries contribute to the rapid adoption of biodegradable packaging.The large manufacturing base and increasing focus on developing cost-effective biodegradable materials in the region support swift market expansion.

Global Biodegradable Pharmaceutical Packaging Market: Segmentation Analysis

The Global Biodegradable Pharmaceutical Packaging Market is segmented on the basis of Material, Product Type, End User, Application and Geography.

Biodegradable Pharmaceutical Packaging Market, By Material

  • Plastics
  • Paper & Paperboard
  • Glass
  • Others

Based on Material, the Biodegradable Pharmaceutical Packaging market is segmented into Plastics, Paper & Paperboard, Glass and Others. Plastics are the most dominating material segment, driven by their versatility, lightweight properties and advancements in biodegradable polymer technologies. The increasing development of bio-based and compostable plastics that can meet the stringent requirements of pharmaceutical packaging, coupled with their potential to significantly reduce carbon footprint, contributes significantly to their market dominance.

Biodegradable Pharmaceutical Packaging Market, By Product Type

  • Bottles
  • Blister Packs
  • Vials & Ampoules
  • Pouches & Sachets
  • Others

Based on Product Type, the Biodegradable Pharmaceutical Packaging market is categorized into Bottles, Blister Packs, Vials & Ampoules, Pouches & Sachets and Others. Bottles are the most dominating product type, driven by their wide usage across various pharmaceutical applications, from liquid medications to solid dosage forms. The ease of incorporating biodegradable materials into bottle manufacturing, along with consumer familiarity and convenience, supports the dominance of bottles in the biodegradable pharmaceutical packaging market.

Biodegradable Pharmaceutical Packaging Market, By End-User

  • Pharmaceutical Manufacturers
  • Contract Packaging Companies
  • Retail Pharmacies
  • Others

Based on End User, the Biodegradable Pharmaceutical Packaging market is segmented into Pharmaceutical Manufacturers, Contract Packaging Companies, Retail Pharmacies and Others. Pharmaceutical Manufacturers is the most dominating end-user segment, driven by the direct control they have over packaging decisions and their increasing commitment to sustainability goals. The growing pressure on pharmaceutical companies to reduce their environmental impact and enhance their corporate social responsibility contributes significantly to the dominance of this segment.

Biodegradable Pharmaceutical Packaging Market, By Application

  • Oral Drugs
  • Injectable
  • Topical Medications
  • Others

Based on Application, the Biodegradable Pharmaceutical Packaging market is segmented into Oral Drugs, Injectable, Topical Medications and Others. Oral Drugs are the most dominating application segment, driven by the high volume of oral medications in the pharmaceutical market and the relative ease of adapting biodegradable packaging for these products. The wide range of oral drug formats, from tablets to liquids and the frequent use of bottles and blister packs that can be made biodegradable, support their significant market share and dominance in the biodegradable pharmaceutical packaging ecosystem.

Biodegradable Pharmaceutical Packaging Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Based on Geography, the Biodegradable Pharmaceutical Packaging market is segmented into Europe, North America, Asia-Pacific, Latin America and the Middle East & Africa. Europe is both the largest and one of the fastest-growing regions, driven by stringent environmental regulations, high consumer awareness and strong government support for sustainable practices. The region's robust pharmaceutical industry, coupled with its leadership in circular economy initiatives and bio-based material development, contributes significantly to its market dominance and continued rapid growth.

Key Players

  • The Global Biodegradable Pharmaceutical Packaging Market study report will provide valuable insight with an emphasis on the global market. The major players in the Biodegradable Pharmaceutical Packaging Market include Gerresheimer AG, Berry Global Inc., Amcor plc, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Eastman Chemical Company, Schott AG, AptarGroup, Inc., Nipro Corporation and CCL Industries Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

  • Biodegradable Pharmaceutical Packaging Market Recent Developments
  • In February 2024, Gerresheimer AG launched a new line of fully biodegradable plastic bottles for liquid medications, made from plant-based materials that can decompose in industrial composting facilities within 6 months. In April 2024, Amcor plc announced a partnership with a leading biotechnology firm to develop a novel biodegradable polymer specifically designed for blister packaging of moisture-sensitive drugs, aiming to replace traditional aluminum-plastic combinations.

TABLE OF CONTENTS

1. INTRODUCTION

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Biodegradable Pharmaceutical Packaging Market, By Material

  • Plastics
  • Paper & Paperboard
  • Glass
  • Others

5. Biodegradable Pharmaceutical Packaging Market, By Product Type

  • Bottles
  • Blister Packs
  • Vials & Ampoules
  • Pouches & Sachets
  • Others

6. Biodegradable Pharmaceutical Packaging Market, By End-User

  • Pharmaceutical Manufacturers
  • Contract Packaging Companies
  • Retail Pharmacies
  • Others

7. Biodegradable Pharmaceutical Packaging Market, By Application

  • Oral Drugs
  • Injectable
  • Topical Medications
  • Others

8. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

9. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

10. Competitive Landscape

  • Key Players
  • Market Share Analysis

11. Company Profiles

  • Gerresheimer AG
  • Berry Global Inc.
  • Amcor plc
  • Becton
  • Dickinson and Company
  • West Pharmaceutical Services Inc.
  • Eastman Chemical Company
  • Schott AG
  • AptarGroup Inc.
  • Nipro Corporation and CCL Industries Inc.

12. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

13. Appendix

  • List of Abbreviations
  • Sources and References